Similar articles for PMID: 20720054

Year	Number of Results
2003	2
2004	1
2005	4
2006	4
2007	6
2008	8
2009	8
2010	10
2011	11
2012	15
2013	9
2014	10
2015	16
2016	5
2017	4
2018	3
2019	2
2021	1
2022	1
2024	0

1

Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements.

Hatt M, Cheze-Le Rest C, Aboagye EO, Kenny LM, Rosso L, Turkheimer FE, Albarghach NM, Metges JP, Pradier O, Visvikis D. Hatt M, et al. J Nucl Med. 2010 Sep;51(9):1368-76. doi: 10.2967/jnumed.110.078501. Epub 2010 Aug 18. J Nucl Med. 2010. PMID: 20720054 Free article.

2

Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.

Thureau S, Chaumet-Riffaud P, Modzelewski R, Fernandez P, Tessonnier L, Vervueren L, Cachin F, Berriolo-Riedinger A, Olivier P, Kolesnikov-Gauthier H, Blagosklonov O, Bridji B, Devillers A, Collombier L, Courbon F, Gremillet E, Houzard C, Caignon JM, Roux J, Aide N, Brenot-Rossi I, Doyeux K, Dubray B, Vera P. Thureau S, et al. J Nucl Med. 2013 Sep;54(9):1543-50. doi: 10.2967/jnumed.112.118083. Epub 2013 Aug 5. J Nucl Med. 2013. PMID: 23918733 Free article. Clinical Trial.

3

Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.

van Westreenen HL, Cobben DC, Jager PL, van Dullemen HM, Wesseling J, Elsinga PH, Plukker JT. van Westreenen HL, et al. J Nucl Med. 2005 Mar;46(3):400-4. J Nucl Med. 2005. PMID: 15750150 Free article. Clinical Trial.

4

Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET.

Kahraman D, Scheffler M, Zander T, Nogova L, Lammertsma AA, Boellaard R, Neumaier B, Ullrich RT, Holstein A, Dietlein M, Wolf J, Kobe C. Kahraman D, et al. J Nucl Med. 2011 Dec;52(12):1871-7. doi: 10.2967/jnumed.111.094458. Epub 2011 Nov 7. J Nucl Med. 2011. PMID: 22065872 Free article. Clinical Trial.

5

Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer.

Frings V, de Langen AJ, Smit EF, van Velden FH, Hoekstra OS, van Tinteren H, Boellaard R. Frings V, et al. J Nucl Med. 2010 Dec;51(12):1870-7. doi: 10.2967/jnumed.110.077255. Epub 2010 Nov 15. J Nucl Med. 2010. PMID: 21078791 Free article.

6

Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology.

Hatt M, Visvikis D, Albarghach NM, Tixier F, Pradier O, Cheze-le Rest C. Hatt M, et al. Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1191-202. doi: 10.1007/s00259-011-1755-7. Epub 2011 Mar 2. Eur J Nucl Med Mol Imaging. 2011. PMID: 21365252 Free article.

7

3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT.

Chen H, Li Y, Wu H, Sun L, Lin Q, Zhao L, An H. Chen H, et al. Strahlenther Onkol. 2015 Feb;191(2):141-52. doi: 10.1007/s00066-014-0744-8. Epub 2014 Aug 28. Strahlenther Onkol. 2015. PMID: 25163419

8

Comparison of characteristics of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET during staging of esophageal squamous cell carcinoma.

Ma C, Li D, Yin Y, Cao J. Ma C, et al. Nucl Med Commun. 2015 Dec;36(12):1181-6. doi: 10.1097/MNM.0000000000000378. Nucl Med Commun. 2015. PMID: 26367213 Clinical Trial.

9

Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.

Han D, Yu J, Yu Y, Zhang G, Zhong X, Lu J, Yin Y, Fu Z, Mu D, Zhang B, He W, Huo Z, Liu X, Kong L, Zhao S, Sun X. Han D, et al. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1235-41. doi: 10.1016/j.ijrobp.2009.07.1681. Epub 2009 Nov 10. Int J Radiat Oncol Biol Phys. 2010. PMID: 19910143

10

Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.

Heijmen L, de Geus-Oei LF, de Wilt JH, Visvikis D, Hatt M, Visser EP, Bussink J, Punt CJ, Oyen WJ, van Laarhoven HW. Heijmen L, et al. Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1858-67. doi: 10.1007/s00259-012-2233-6. Epub 2012 Sep 4. Eur J Nucl Med Mol Imaging. 2012. PMID: 22945372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year